ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Drug and Device Microbiological Sterility Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-30H17005
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medical Drug and Device Microbiological Sterility Testing Market Research Report 2024
BUY CHAPTERS

Global Medical Drug and Device Microbiological Sterility Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30H17005
Report
November 2025
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Steris
Charles River Laboratories International, Inc.
Thermo Fisher Scientific Inc
SGS Ltd
Sartorius
Sotera Health Company
Pacific BioLabs Inc.
Laboratory Corporation of America Holdings
Almac Group
Pace Analytical Services, LLC.

Medical Drug and Device Microbiological Sterility Testing Market

The global Medical Drug and Device Microbiological Sterility Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Medical Drug and Device Microbiological Sterility Testing is a process aimed at determining the absence of viable microorganisms in pharmaceutical products, ensuring their safety and efficacy. This rigorous testing involves methods such as membrane filtration or direct inoculation, followed by incubation to allow for microbial growth detection. Regulatory agencies mandate sterility testing to uphold stringent quality standards and minimize the risk of contamination in products intended for sterile administration routes.
From a downstream perspective, Medical Drugs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Medical Drug and Device Microbiological Sterility Testing leading manufacturers including Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings, Almac Group, Pace Analytical Services, LLC, etc., dominate supply; the top five capture approximately % of global revenue, with Steris PLC leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Drug and Device Microbiological Sterility Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Medical Drug and Device Microbiological Sterility Testing Market Report

Report Metric Details
Report Name Medical Drug and Device Microbiological Sterility Testing Market
Segment by Type
  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
Segment by Application
  • Medical Drugs
  • Medical Devices
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings, Almac Group, Pace Analytical Services, LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Medical Drug and Device Microbiological Sterility Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Medical Drug and Device Microbiological Sterility Testing Market report?

Ans: The main players in the Medical Drug and Device Microbiological Sterility Testing Market are Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings, Almac Group, Pace Analytical Services, LLC

What are the Application segmentation covered in the Medical Drug and Device Microbiological Sterility Testing Market report?

Ans: The Applications covered in the Medical Drug and Device Microbiological Sterility Testing Market report are Medical Drugs, Medical Devices

What are the Type segmentation covered in the Medical Drug and Device Microbiological Sterility Testing Market report?

Ans: The Types covered in the Medical Drug and Device Microbiological Sterility Testing Market report are Bioburden Testing, Sterility Testing, Bacterial Endotoxin Testing

1 Study Coverage
1.1 Introduction to Medical Drug and Device Microbiological Sterility Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bioburden Testing
1.2.3 Sterility Testing
1.2.4 Bacterial Endotoxin Testing
1.3 Market Segmentation by Application
1.3.1 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Drugs
1.3.3 Medical Devices
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Medical Drug and Device Microbiological Sterility Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Medical Drug and Device Microbiological Sterility Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Bioburden Testing Market Size by Players
3.3.2 Sterility Testing Market Size by Players
3.3.3 Bacterial Endotoxin Testing Market Size by Players
3.4 Global Medical Drug and Device Microbiological Sterility Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Medical Drug and Device Microbiological Sterility Testing Market Size by Type (2020-2031)
6.4 North America Medical Drug and Device Microbiological Sterility Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medical Drug and Device Microbiological Sterility Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Medical Drug and Device Microbiological Sterility Testing Market Size by Type (2020-2031)
7.4 Europe Medical Drug and Device Microbiological Sterility Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medical Drug and Device Microbiological Sterility Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Medical Drug and Device Microbiological Sterility Testing Market Size by Type (2020-2031)
9.4 Central and South America Medical Drug and Device Microbiological Sterility Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medical Drug and Device Microbiological Sterility Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Steris PLC
11.1.1 Steris PLC Corporation Information
11.1.2 Steris PLC Business Overview
11.1.3 Steris PLC Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.1.4 Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.1.5 Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue by Product in 2024
11.1.6 Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue by Application in 2024
11.1.7 Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue by Geographic Area in 2024
11.1.8 Steris PLC Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
11.1.9 Steris PLC Recent Developments
11.2 Charles River Laboratories International, Inc.
11.2.1 Charles River Laboratories International, Inc. Corporation Information
11.2.2 Charles River Laboratories International, Inc. Business Overview
11.2.3 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.2.4 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.2.5 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue by Product in 2024
11.2.6 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue by Application in 2024
11.2.7 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue by Geographic Area in 2024
11.2.8 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
11.2.9 Charles River Laboratories International, Inc. Recent Developments
11.3 Thermo Fisher Scientific, Inc.
11.3.1 Thermo Fisher Scientific, Inc. Corporation Information
11.3.2 Thermo Fisher Scientific, Inc. Business Overview
11.3.3 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.3.4 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.3.5 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue by Product in 2024
11.3.6 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue by Application in 2024
11.3.7 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue by Geographic Area in 2024
11.3.8 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
11.3.9 Thermo Fisher Scientific, Inc. Recent Developments
11.4 SGS S.A.
11.4.1 SGS S.A. Corporation Information
11.4.2 SGS S.A. Business Overview
11.4.3 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.4.4 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.4.5 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue by Product in 2024
11.4.6 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue by Application in 2024
11.4.7 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue by Geographic Area in 2024
11.4.8 SGS S.A. Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
11.4.9 SGS S.A. Recent Developments
11.5 Sartorius AG
11.5.1 Sartorius AG Corporation Information
11.5.2 Sartorius AG Business Overview
11.5.3 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.5.4 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.5.5 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue by Product in 2024
11.5.6 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue by Application in 2024
11.5.7 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue by Geographic Area in 2024
11.5.8 Sartorius AG Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
11.5.9 Sartorius AG Recent Developments
11.6 Sotera Health Company
11.6.1 Sotera Health Company Corporation Information
11.6.2 Sotera Health Company Business Overview
11.6.3 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.6.4 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.6.5 Sotera Health Company Recent Developments
11.7 Pacific Biolabs, Inc.
11.7.1 Pacific Biolabs, Inc. Corporation Information
11.7.2 Pacific Biolabs, Inc. Business Overview
11.7.3 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.7.4 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.7.5 Pacific Biolabs, Inc. Recent Developments
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Corporation Information
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.8.4 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.8.5 Laboratory Corporation of America Holdings Recent Developments
11.9 Almac Group
11.9.1 Almac Group Corporation Information
11.9.2 Almac Group Business Overview
11.9.3 Almac Group Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.9.4 Almac Group Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.9.5 Almac Group Recent Developments
11.10 Pace Analytical Services, LLC
11.10.1 Pace Analytical Services, LLC Corporation Information
11.10.2 Pace Analytical Services, LLC Business Overview
11.10.3 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Product Features and Attributes
11.10.4 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Medical Drug and Device Microbiological Sterility TestingIndustry Chain Analysis
12.1 Medical Drug and Device Microbiological Sterility Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medical Drug and Device Microbiological Sterility Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medical Drug and Device Microbiological Sterility Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Steris
Charles River Laboratories International, Inc.
Thermo Fisher Scientific Inc
SGS Ltd
Sartorius
Sotera Health Company
Pacific BioLabs Inc.
Laboratory Corporation of America Holdings
Almac Group
Pace Analytical Services, LLC.
List of Tables
 Table 1. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Medical Drug and Device Microbiological Sterility Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Medical Drug and Device Microbiological Sterility Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Drug and Device Microbiological Sterility Testing as of 2024)
 Table 11. Global Medical Drug and Device Microbiological Sterility Testing Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Medical Drug and Device Microbiological Sterility Testing Companies Headquarters
 Table 13. Global Medical Drug and Device Microbiological Sterility Testing Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Medical Drug and Device Microbiological Sterility Testing High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Medical Drug and Device Microbiological Sterility Testing Growth Accelerators and Market Barriers
 Table 25. North America Medical Drug and Device Microbiological Sterility Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Medical Drug and Device Microbiological Sterility Testing Growth Accelerators and Market Barriers
 Table 27. Europe Medical Drug and Device Microbiological Sterility Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Medical Drug and Device Microbiological Sterility Testing Investment Opportunities and Key Challenges
 Table 31. Central and South America Medical Drug and Device Microbiological Sterility Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Steris PLC Corporation Information
 Table 35. Steris PLC Description and Major Businesses
 Table 36. Steris PLC Product Features and Attributes
 Table 37. Steris PLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Steris PLC Revenue Proportion by Product in 2024
 Table 39. Steris PLC Revenue Proportion by Application in 2024
 Table 40. Steris PLC Revenue Proportion by Geographic Area in 2024
 Table 41. Steris PLC Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
 Table 42. Steris PLC Recent Developments
 Table 43. Charles River Laboratories International, Inc. Corporation Information
 Table 44. Charles River Laboratories International, Inc. Description and Major Businesses
 Table 45. Charles River Laboratories International, Inc. Product Features and Attributes
 Table 46. Charles River Laboratories International, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Charles River Laboratories International, Inc. Revenue Proportion by Product in 2024
 Table 48. Charles River Laboratories International, Inc. Revenue Proportion by Application in 2024
 Table 49. Charles River Laboratories International, Inc. Revenue Proportion by Geographic Area in 2024
 Table 50. Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
 Table 51. Charles River Laboratories International, Inc. Recent Developments
 Table 52. Thermo Fisher Scientific, Inc. Corporation Information
 Table 53. Thermo Fisher Scientific, Inc. Description and Major Businesses
 Table 54. Thermo Fisher Scientific, Inc. Product Features and Attributes
 Table 55. Thermo Fisher Scientific, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Thermo Fisher Scientific, Inc. Revenue Proportion by Product in 2024
 Table 57. Thermo Fisher Scientific, Inc. Revenue Proportion by Application in 2024
 Table 58. Thermo Fisher Scientific, Inc. Revenue Proportion by Geographic Area in 2024
 Table 59. Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
 Table 60. Thermo Fisher Scientific, Inc. Recent Developments
 Table 61. SGS S.A. Corporation Information
 Table 62. SGS S.A. Description and Major Businesses
 Table 63. SGS S.A. Product Features and Attributes
 Table 64. SGS S.A. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. SGS S.A. Revenue Proportion by Product in 2024
 Table 66. SGS S.A. Revenue Proportion by Application in 2024
 Table 67. SGS S.A. Revenue Proportion by Geographic Area in 2024
 Table 68. SGS S.A. Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
 Table 69. SGS S.A. Recent Developments
 Table 70. Sartorius AG Corporation Information
 Table 71. Sartorius AG Description and Major Businesses
 Table 72. Sartorius AG Product Features and Attributes
 Table 73. Sartorius AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Sartorius AG Revenue Proportion by Product in 2024
 Table 75. Sartorius AG Revenue Proportion by Application in 2024
 Table 76. Sartorius AG Revenue Proportion by Geographic Area in 2024
 Table 77. Sartorius AG Medical Drug and Device Microbiological Sterility Testing SWOT Analysis
 Table 78. Sartorius AG Recent Developments
 Table 79. Sotera Health Company Corporation Information
 Table 80. Sotera Health Company Description and Major Businesses
 Table 81. Sotera Health Company Product Features and Attributes
 Table 82. Sotera Health Company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Sotera Health Company Recent Developments
 Table 84. Pacific Biolabs, Inc. Corporation Information
 Table 85. Pacific Biolabs, Inc. Description and Major Businesses
 Table 86. Pacific Biolabs, Inc. Product Features and Attributes
 Table 87. Pacific Biolabs, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Pacific Biolabs, Inc. Recent Developments
 Table 89. Laboratory Corporation of America Holdings Corporation Information
 Table 90. Laboratory Corporation of America Holdings Description and Major Businesses
 Table 91. Laboratory Corporation of America Holdings Product Features and Attributes
 Table 92. Laboratory Corporation of America Holdings Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Laboratory Corporation of America Holdings Recent Developments
 Table 94. Almac Group Corporation Information
 Table 95. Almac Group Description and Major Businesses
 Table 96. Almac Group Product Features and Attributes
 Table 97. Almac Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Almac Group Recent Developments
 Table 99. Pace Analytical Services, LLC Corporation Information
 Table 100. Pace Analytical Services, LLC Description and Major Businesses
 Table 101. Pace Analytical Services, LLC Product Features and Attributes
 Table 102. Pace Analytical Services, LLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Pace Analytical Services, LLC Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Medical Drug and Device Microbiological Sterility Testing Product Picture
 Figure 2. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Bioburden Testing Product Picture
 Figure 4. Sterility Testing Product Picture
 Figure 5. Bacterial Endotoxin Testing Product Picture
 Figure 6. Global Medical Drug and Device Microbiological Sterility Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Medical Drugs
 Figure 8. Medical Devices
 Figure 9. Medical Drug and Device Microbiological Sterility Testing Report Years Considered
 Figure 10. Global Medical Drug and Device Microbiological Sterility Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Medical Drug and Device Microbiological Sterility Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Region (2020-2031)
 Figure 14. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Bioburden Testing Revenue Market Share by Player in 2024
 Figure 17. Sterility Testing Revenue Market Share by Player in 2024
 Figure 18. Bacterial Endotoxin Testing Revenue Market Share by Player in 2024
 Figure 19. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Type (2020-2031)
 Figure 20. Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Application (2020-2031)
 Figure 21. North America Medical Drug and Device Microbiological Sterility Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) in 2024
 Figure 23. North America Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Medical Drug and Device Microbiological Sterility Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) in 2024
 Figure 30. Europe Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 33. France Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 45. India Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Medical Drug and Device Microbiological Sterility Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) in 2024
 Figure 53. Central and South America Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) in 2024
 Figure 59. South America Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Medical Drug and Device Microbiological Sterility Testing Revenue (2020-2025) & (US$ Million)
 Figure 65. Medical Drug and Device Microbiological Sterility Testing Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Pharmaceutical Microbiology Sterility Testing Market Research Report 2024
Global Medical Device Sterilization and Microbiology Testing Service Market Research Report 2024
Global Microbial and Sterility Test Market Research Report 2024
Global Medical Device and Pharmaceutical Sterility Testing Market Insights Forecast to 2030
Pharmaceutical Sterility Testing Market
Global Medical Device Sterilization Market Research Report 2024
Medical Device Sterilization and Microbiology Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Testing Market Research Report 2024
Global Microbial Testing Service Market Research Report 2024
Global Sterilizers for Medical Devices Market Research Report 2025
Global Pharmaceutical and Medical Device Testing Market Research Report 2024
Global Sterilization Instruments Market Research Report 2025
Global Pharmaceuticals Sterilization Service Market Research Report 2024
Global EMEA Sterility Testing Market Research Report 2025
Global Medical Sterilization Equipment Market Research Report 2025
Global Microbiological Testing Service Market Research Report 2024
Global Filtration Sterilizer Market Research Report 2025
Global Microbial Testing and Identification Services Market Research Report 2024
Microbiological Test Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterility Test Isolators Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions